Larvol Delta - Atossa-Completes-Enrollment-of-Pharmacokinetic-RunIn-Cohort-in-Phase-2-EVANGELINE-Clinical-Trial-Evaluating-ZEndoxifen-as-a-Neoadjuvant-Treatment-for-ER--HER2-Breast-Cancer

Z-endoxifen - Atossa Therap

https://www.globenewswire.com/us/news-release/2023/06/12/2686379/0/en/Atossa-Completes-Enrollment-of-Pharmacokinetic-Run-In-Cohort-in-Phase-2-EVANGELINE-Clinical-Trial-Evaluating-Z-Endoxifen-as-a-Neoadjuvant-Treatment-for-ER-HER2-Breast-Cancer.html

Jun 12, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next